Miho Kono

526 total citations
22 papers, 430 citations indexed

About

Miho Kono is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Miho Kono has authored 22 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Miho Kono's work include Lung Cancer Treatments and Mutations (6 papers), Cancer Treatment and Pharmacology (4 papers) and Lung Cancer Research Studies (4 papers). Miho Kono is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer Treatment and Pharmacology (4 papers) and Lung Cancer Research Studies (4 papers). Miho Kono collaborates with scholars based in Japan, United States and United Kingdom. Miho Kono's co-authors include Naoto T. Ueno, Takeo Fujii, Meghan Karuturi, Debasish Tripathy, Bora Lim, S. Osawa, Hiroyuki Nagasawa, Tasuku Watanabe, Masaru Mitsutomi and Daisuke Koga and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and European Journal of Cancer.

In The Last Decade

Miho Kono

21 papers receiving 420 citations

Peers

Miho Kono

ONCOL

PRM

GENET

Ewa Małusecka Poland

Guang-Xin Xu China

Xicai Wang China

Debjani Pal United States

Huan Gao China

Yuichi Kawanishi Japan

J. L. Schwartz United States

Joseph A. Dunn United States

Miriam Fine United States

Márcia Maria Urbanin Castanhole-Nunes Brazil

Ewa Małusecka Poland

Miho Kono

404 ×1.7

73 ×0.6

ONCOL

57 ×0.6

PRM

36 ×0.5

GENET

186 ×2.4

Citations per year, relative to Miho Kono Miho Kono (= 1×) peers Ewa Małusecka

Countries citing papers authored by Miho Kono

Since Specialization

Citations

This map shows the geographic impact of Miho Kono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miho Kono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miho Kono more than expected).

Fields of papers citing papers by Miho Kono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miho Kono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miho Kono. The network helps show where Miho Kono may publish in the future.

Co-authorship network of co-authors of Miho Kono

This figure shows the co-authorship network connecting the top 25 collaborators of Miho Kono. A scholar is included among the top collaborators of Miho Kono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miho Kono. Miho Kono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matsuura, K., et al.. (2025). A Phase II Study of Accelerated Hyperfractionated Thoracic Radiotherapy With Dose Escalation to 54 Gy With Concurrent Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Long-Term Results at a Single Institution. Clinical Lung Cancer. 26(8). 651–658.

Kono, Miho, Malek Shatila, Guofan Xu, et al.. (2023). Obesity Measured via Body Mass Index May Be Associated with Increased Incidence but Not Worse Outcomes of Immune-Mediated Diarrhea and Colitis. Cancers. 15(8). 2329–2329. 4 indexed citations

Kono, Miho, Guofan Xu, Malek Shatila, et al.. (2022). Characteristics, treatment, and outcome of diverticulitis after immune checkpoint inhibitor treatment in patients with malignancies. Journal of Cancer Research and Clinical Oncology. 149(8). 4805–4816. 2 indexed citations

Kono, Miho, Takeo Fujii, Naoko Matsuda, et al.. (2018). Somatic mutations, clinicopathologic characteristics, and survival in patients with untreated breast cancer with bone-only and non-bone sites of first metastasis. Journal of Cancer. 9(19). 3640–3646. 20 indexed citations

Kono, Miho, Pamela K. Allen, Steven H. Lin, et al.. (2017). Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small–Cell Lung Cancer and Its Effects on Survival. Journal of Thoracic Oncology. 12(11). 1696–1703. 12 indexed citations

Kono, Miho, Takeo Fujii, Bora Lim, et al.. (2017). Androgen Receptor Function and Androgen Receptor–Targeted Therapies in Breast Cancer. JAMA Oncology. 3(9). 1266–1266. 167 indexed citations

Fujii, Takeo, Naoko Matsuda, Miho Kono, et al.. (2017). Prior systemic treatment increased the incidence of somatic mutations in metastatic breast cancer. European Journal of Cancer. 89. 64–71. 3 indexed citations

Kadoya, Takayuki, Makoto Fujiwara, Toru Yoshikawa, et al.. (2017). Dedicated breast PET to improve clinical diagnosis of breast cancer: Initial evaluation.. Journal of Clinical Oncology. 35(15_suppl). e12097–e12097. 2 indexed citations

Kono, Miho, Pamela K. Allen, Steven H. Lin, et al.. (2016). Incidence of and Survival Outcomes After Metachronous Second Primary Malignancy After the Treatment of Limited-Stage Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). E430–E430. 1 indexed citations

10.

Kono, Miho, Takeo Fujii, Genevieve Lyons, et al.. (2016). Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy. Breast Cancer Research and Treatment. 160(1). 101–109. 14 indexed citations

11.

Sugiura, Katsuaki, et al.. (2015). Annular Elastolytic Giant Cell Granuloma Successfully Treated with Minocycline Hydrochloride. Acta Dermato Venereologica. 95(6). 756–757. 8 indexed citations

12.

Kono, Miho, Yasuhiko Sakata, Keisuke Abé, et al.. (2014). [Assessment of risk factors for adverse events due to pemetrexed in patients with reduced renal function].. PubMed. 41(13). 2587–90. 1 indexed citations

13.

Koga, Daisuke, Masaru Mitsutomi, Miho Kono, & Masahiro Matsumiya. (1999). Biochemistry of chitinases. Birkhäuser Basel eBooks. 87. 111–123. 49 indexed citations

14.

Watanabe, Tasuku, et al.. (1998). Purification and molecular cloning of a chitinase expressed in the hepatopancreas of the penaeid prawn Penaeus japonicus. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1382(2). 181–185. 57 indexed citations

15.

Soejima, Toshinori, et al.. (1991). [Histopathological study of the esophageal injury induced by high-dose-rate intracavitary irradiation].. PubMed. 51(8). 976–8. 1 indexed citations

16.

Ueda, Emi, et al.. (1989). [Experimental study of arterial damage induced by anti-cancer drug infusion].. PubMed. 49(11). 1430–2. 1 indexed citations

17.

Iwabuchi, M., Eiko Otaka, Miho Kono, & S. Osawa. (1966). The effect of 5-fluorouracil on the ribosome formation in Escherichia coli. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 114(1). 83–94. 10 indexed citations

18.

Iwabuchi, M., Miho Kono, T. Oumi, & S. Osawa. (1965). The RNA components in ribonucleoprotein particles occurring during the course of ribosome formation in Escherichia coli. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 108(2). 211–219. 32 indexed citations

19.

Kono, Miho, Eiko Otaka, & S. Osawa. (1964). Changes in sedimentation properties of ribosomal ribonucleic acids during the course of ribosome formation in Escherichia coli. Biochimica et Biophysica Acta (BBA) - Specialized Section on Nucleic Acids and Related Subjects. 91(4). 612–618. 27 indexed citations

20.

Kono, Miho & Shigehiko Taniguchi. (1960). Hydroxylamine reductase of a halotolerant micrococcus. Biochimica et Biophysica Acta. 43. 419–430. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact